Lipopolysaccharide from Gut-Associated Lymphoid-Tissue-Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A
- PMID: 33522128
- PMCID: PMC8252424
- DOI: 10.1002/anie.202012374
Lipopolysaccharide from Gut-Associated Lymphoid-Tissue-Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A
Abstract
Alcaligenes faecalis is the predominant Gram-negative bacterium inhabiting gut-associated lymphoid tissues, Peyer's patches. We previously reported that an A. faecalis lipopolysaccharide (LPS) acted as a weak agonist for Toll-like receptor 4 (TLR4)/myeloid differentiation factor-2 (MD-2) receptor as well as a potent inducer of IgA without excessive inflammation, thus suggesting that A. faecalis LPS might be used as a safe adjuvant. In this study, we characterized the structure of both the lipooligosaccharide (LOS) and LPS from A. faecalis. We synthesized three lipid A molecules with different degrees of acylation by an efficient route involving the simultaneous introduction of 1- and 4'-phosphates. Hexaacylated A. faecalis lipid A showed moderate agonistic activity towards TLR4-mediated signaling and the ability to elicit a discrete interleukin-6 release in human cell lines and mice. It was thus found to be the active principle of the LOS/LPS and a promising vaccine adjuvant candidate.
Keywords: glycolipids; lipid A; lipopolysaccharides; oligosaccharides; vaccines.
© 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Lymphoid tissue-resident Alcaligenes LPS induces IgA production without excessive inflammatory responses via weak TLR4 agonist activity.Mucosal Immunol. 2018 May;11(3):693-702. doi: 10.1038/mi.2017.103. Epub 2018 Feb 7. Mucosal Immunol. 2018. PMID: 29411777
-
Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria Alcaligenes faecalis Functions as an Effective Nasal Adjuvant to Augment IgA Antibody and Th17 Cell Responses.Front Immunol. 2021 Jul 1;12:699349. doi: 10.3389/fimmu.2021.699349. eCollection 2021. Front Immunol. 2021. PMID: 34276692 Free PMC article.
-
Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide: combined effects of lipid A acylation state and TLR4 polymorphisms on signaling.J Immunol. 2008 Jan 15;180(2):1139-47. doi: 10.4049/jimmunol.180.2.1139. J Immunol. 2008. PMID: 18178854 Free PMC article.
-
Lipid A-Mediated Bacterial-Host Chemical Ecology: Synthetic Research of Bacterial Lipid As and Their Development as Adjuvants.Molecules. 2021 Oct 18;26(20):6294. doi: 10.3390/molecules26206294. Molecules. 2021. PMID: 34684874 Free PMC article. Review.
-
Synthetic TLR4-active glycolipids as vaccine adjuvants and stand-alone immunotherapeutics.Curr Top Med Chem. 2008;8(2):64-79. doi: 10.2174/156802608783378882. Curr Top Med Chem. 2008. PMID: 18289078 Review.
Cited by
-
Synthesis and biological evaluation of lipid A derived from commensal Bacteroides.Org Biomol Chem. 2024 Nov 13;22(44):8793-8800. doi: 10.1039/d4ob01340a. Org Biomol Chem. 2024. PMID: 39400282 Free PMC article.
-
The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity.Nat Commun. 2024 Sep 27;15(1):8411. doi: 10.1038/s41467-024-52683-x. Nat Commun. 2024. PMID: 39333588 Free PMC article.
-
In Vitro Anti-Inflammatory Study of Limonoids Isolated from Chisocheton Plants.Curr Issues Mol Biol. 2024 Jan 20;46(1):909-922. doi: 10.3390/cimb46010058. Curr Issues Mol Biol. 2024. PMID: 38275672 Free PMC article.
-
Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue.Int Immunol. 2024 Jan 29;36(1):33-43. doi: 10.1093/intimm/dxad045. Int Immunol. 2024. PMID: 38006376 Free PMC article.
-
Heterogeneity of Lipopolysaccharide as Source of Variability in Bioassays and LPS-Binding Proteins as Remedy.Int J Mol Sci. 2023 May 7;24(9):8395. doi: 10.3390/ijms24098395. Int J Mol Sci. 2023. PMID: 37176105 Free PMC article. Review.
References
-
- None
-
- Vatanen T., Kostic A. D., d'Hennezel E., Siljander H., Franzosa E. A., Yassour M., Kolde R., Vlamakis H., Arthur T. D., Hamalainen A. M., Peet A., Tillmann V., Uibo R., Mokurov S., Dorshakova N., Ilonen J., Virtanen S. M., Szabo S. J., Porter J. A., Lahdesmaki H., Huttenhower C., Gevers D., Cullen T. W., Knip M., Group D. S., Xavier R. J., Cell 2016, 165, 842–853; - PMC - PubMed
-
- Di Lorenzo F., De Castro C., Silipo A., Molinaro A., FEMS Microbiol. Rev. 2019, 43, 257–272; - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
